NASDAQ:XERS
Xeris Biopharma Holdings, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.xerispharma.comcrunchbase
xeris-pharmaceuticalslinkedin
xeris-pharmaceuticalsfounding date
Jan 01, 2005ipo date
Jun 21, 2018
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus